These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4005107)

  • 21. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage.
    Linday LA; Greenblatt DJ; Warren MP; Harmatz JS; DeCresce R; Cicalese C; LeDuc BW
    Dev Pharmacol Ther; 1991; 16(4):194-202. PubMed ID: 1782837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
    Moreland TA; Park BK; Rylance GW
    Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy and clinical utility of simplified tests of antipyrine metabolism.
    Farrell GC; Zaluzny L
    Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolism of antipyrine during pregnancy].
    Koroleva GA; Semeniuk AV; Kolesnikova LI; Skosyreva GA
    Farmakol Toksikol; 1986; 49(6):92-4. PubMed ID: 3817154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
    Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
    Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metronidazole clearance: a one-sample method and influencing factors.
    Loft S; Poulsen HE; Sonne J; Døssing M
    Clin Pharmacol Ther; 1988 Apr; 43(4):420-8. PubMed ID: 3356085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The determination of antipyrine elimination in saliva by liquid chromatography.
    Gartzke J; Jäger H
    J Pharm Biomed Anal; 1991; 9(10-12):977-9. PubMed ID: 1822222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
    Eichelbaum M; Bertilsson L; Säwe J
    Br J Clin Pharmacol; 1983 Mar; 15(3):317-21. PubMed ID: 6849767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipyrine clearance during occupational exposure to styrene.
    Døssing M
    Br J Ind Med; 1983 May; 40(2):224-8. PubMed ID: 6131688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of antipyrine clearance in psoriasis.
    Marsden JR; Williams FM; Keys B; Rawlins MD; Shuster S
    Br J Clin Pharmacol; 1984 Mar; 17(3):331-3. PubMed ID: 6712866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipyrine clearance and metabolism in patients with psoriasis.
    Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
    Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary disease and antipyrine clearance.
    Laybourn C; Tønnesen P; Loft S; Sonne J; Døssing M
    Clin Pharmacol Ther; 1986 Oct; 40(4):415-9. PubMed ID: 3489577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.